MedPath

Cerebrovascular Autoregulation During and After Liver Transplantation

Conditions
Encephalopathy, Hepatic
Cerebrovascular Disorders
Liver Failure
Registration Number
NCT01597102
Lead Sponsor
Johannes Gutenberg University Mainz
Brief Summary

The cerebrovascular autoregulation (AR) is impaired in patients with hepatic encephalopathy. Patients with the indication to liver transplantation mostly have mild to severe hepatic encephalopathy. Transplantation should recover the encephalopathy. The aim of the study is to investigate the AR during liver transplantation, with the questions if the AR is impaired at the beginning of surgery and if there are changes in AR. For follow up the AR will be measured at the first days after transplantation at the ICU.

Detailed Description

The cerebrovascular autoregulation (AR) will be measured using transcranial doppler and calculating the index of autoregulation Mx. This measurement is continuous with online calculation. So, the possible changes over the whole time of surgery can be detected. Furthermore, the measurement of AR at the ICU will be performed daily at the same time over a measurement period of 60 Minutes and the time course of AR after liver transplantation will be described.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • liver transplantation
  • age > 18 years
Exclusion Criteria
  • sepsis
  • preexisting cerebral diseases
  • traumatic brain injury
  • pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes of cerebrovascular autoregulation during liver transplantationDuring the surgery

Measuring cerebrovascular autoregulation during the whole liver transplantation and compare the index of AR at the beginning with index of AR Mx after reperfusion of the transplantated liver

Secondary Outcome Measures
NameTimeMethod
Time course of cerebrovascular autoregulation after liver transplantationFirst 4 days after transplantation

Meaurement of cerebrovascular autoregulation daily for the first 4 days and calculating a time course

Trial Locations

Locations (1)

University Medical Center

🇩🇪

Mainz, Germany

University Medical Center
🇩🇪Mainz, Germany
Patrick Schramm, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.